# Statins in Chronic Hepatitis C Patients Receiving Sofosbuvir/Daclatasvir Combination

> **NCT03490097** · PHASE2,PHASE3 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 100 (actual)

## Conditions studied

- Chronic Hepatitis c
- Metabolic Syndrome

## Interventions

- **DRUG:** Simvastatin 10mg
- **DRUG:** sofosbuvir plus daclatasvir

## Key facts

- **NCT ID:** NCT03490097
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-01
- **Primary completion:** 2018-05-23
- **Final completion:** 2018-05-23
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2018-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03490097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03490097, "Statins in Chronic Hepatitis C Patients Receiving Sofosbuvir/Daclatasvir Combination". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03490097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*